NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE75118 Query DataSets for GSE75118
Status Public on Nov 17, 2016
Title Expression Profile of alloreactive CD8 and CD4 induced regulatory T cells
Organism Mus musculus
Experiment type Expression profiling by array
Summary Adoptive natural regulatory T cell (nTreg) therapy has improved the outcome for patients suffering from graft-versus-host disease (GVHD) following allogeneic hematopoietic cell transplantation (allo-HCT). However, fear of broad immune suppression and subsequent dampening of beneficial graft-versus-leukemic (GVL) responses remains a challenge. To address this concern, we generated alloreactive induced Tregs (iTregs) from resting CD4 or CD8 T cells and tested their ability to suppress GVH and maintain GVL responses. We utilized major mismatched and haploidentical murine models of HCT with host-derived lymphoma or leukemia cell lines to evaluate GVH and GVL responses simultaneously. Alloreactive CD4 iTregs were effective in preventing GVHD, but abrogated the GVL effect against aggressive leukemia. Alloreactive CD8 iTregs moderately attenuated GVHD while sparing the GVL effect. Hence, we reasoned that using a combination of CD4 and CD8 iTregs could achieve the optimal goal of allo-HCT. Indeed, the combinational therapy was superior to CD4 or CD8 iTreg singular therapy in GVHD control; importantly, the combinational therapy maintained GVL responses. Cellular analysis uncovered potent suppression of both CD4 and CD8 effector T cells by the combinational therapy that resulted in effective prevention of GVHD, which could not be achieved by either singular therapy. Gene expression profiles revealed alloreactive CD8 iTregs possess elevated expression of multiple cytolytic molecules compared to CD4 iTregs, which likely contributes to GVL preservation. Our study uncovers unique differences between alloreactive CD4 and CD8 iTregs that can be harnessed to create an optimal iTreg therapy for GVHD prevention with maintained GVL responses.
 
Overall design 12 samples analyzed, experimental groups (n=3) were CD8+GFP+ and n=3 CD4+GFP+, with GFP being a reporter for Foxp3 expression; controls (n=3) were CD8+GFP- and CD4+GFP-.
 
Contributor(s) Heinrichs J, Li J, Nguyen H, Wu Y, Bastian D, Daethanasanmak A, Sofi M, Schutt S, Liu C, Jin J, Betts B, Anasetti C, Yu X
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date Nov 17, 2015
Last update date Feb 21, 2018
Contact name Jessica Heinrichs
E-mail(s) heinric@musc.edu
Phone 813-748-0946
Organization name Medical University
Department Microbiology and Immunology
Lab Xue-Zhong Yu
Street address 86 Johnathan Lucas Street
City Charleston
State/province South Carolina
ZIP/Postal code 29425
Country USA
 
Platforms (1)
GPL16570 [MoGene-2_0-st] Affymetrix Mouse Gene 2.0 ST Array [transcript (gene) version]
Samples (12)
GSM1943591 CD8_repA
GSM1943592 CD8_repB
GSM1943593 CD8_repC
Relations
BioProject PRJNA302534

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE75118_RAW.tar 107.5 Mb (http)(custom) TAR (of CEL)
Processed data included within Sample table

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap